PDCD1 and Miyoshi myopathy: Moreover, we did not observe the significant increase of PD1, LAG3, TIGIT, the classic immune checkpoints, on immune cells, which could help us to explain the reason of the unfavorable treatment efficacy of immune checkpoint inhibitors in MM clinic practices.